Give Online: Help shape patient care for generations to come.
Cleveland Clinic Children's Hospital

Giovanni Piedimonte, MD

216.444.5437

Giovanni Piedimonte, MD

Appointed: 2012

No Patient Satisfaction Reviews
Giovanni Piedimonte, MD
Department: Pediatric Institute
Institute Chair
Location: Cleveland Clinic Main Campus
Mail Code A111
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5437
DeskDesk:216.444.9320
WorkFax:216.445.3797
Surgeon:
No
Type of Doctor:
Children & Adolescents Only

Biographical Sketch

Giovanni Piedimonte, MD, is the Steven and Nancy Calabrese Endowed Chair for Excellence in Pediatric Care, Research, and Education and Professor & Chair of Pediatrics of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He also serves as Chairman of the Cleveland Clinic Pediatric Institute, Physician-in-Chief of the Cleveland Clinic Children’s Hospital, and President of the Cleveland Clinic Children’s Hospital for Rehabilitation in Cleveland, Ohio. Previously, he served for more than 6 years as the first Wyeth Research Scholar, Professor and Chairman of the Department of Pediatrics at West Virginia University School of Medicine, and Physician-in-Chief of the WVU Children’s Hospital in Morgantown, WV. 

 

Education and Training: Dr. Piedimonte received his degree in Medicine from the University Of Rome School Of Medicine in Italy, completed his residency training in Pediatrics at the University of California San Francisco, and received fellowship training at the Cardiovascular Research Institute of the University of California San Francisco and at the University of North Carolina Chapel Hill. He maintains an active clinical practice and holds certifications in General Pediatrics and in Pediatric Pulmonology from the American Board of Pediatrics. 

 Research, Publications and Speaking: Dr. Piedimonte’s research has been funded by the National Institutes of Health (NIH) for more than 28 consecutive years and he has been principal investigator or co-investigator of more than 30 research projects funded by the NIH, the National Cystic Fibrosis Foundation, the American Lung Association, the Asthma and Allergy Foundation of America, and the pharmaceutical industry. 

Dr. Piedimonte has authored or co-authored over 350 peer-reviewed journal articles, book chapters, monographs, editorials, and abstracts with the primary focus on airway inflammation in childhood respiratory disease, the role of early viral respiratory infections in the pathogenesis of asthma, and the neurobiology of the developing respiratory tract. His articles have been published in journals such as the Journal of Clinical Investigation, American Journal of Physiology, Journal of Pharmacology and Experimental Therapeutics, Circulation Research, American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, Pediatrics, Pediatric Research, and the Public Library of Science (PLoS). 

Dr. Piedimonte serves on the editorial boards of several scientific journals, including Pediatric Pulmonology, Pediatric Allergy Immunology & Pulmonology, Current Pediatric Reviews, and Current Opinion in Pharmacology. He is also a regular reviewer for a number of other leading journals, including The Medical Letter, PLoS, The British Medical Journal, American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, Thorax, American Journal of Physiology, Journal of Immunology, Pediatrics, Journal of Pediatrics, Pediatric Research, and the Archives of Disease in Childhood. 

Dr. Piedimonte has been an invited speaker nationally and internationally on more than 450 occasions, including being the recipient of the European Society for Paediatric Hematology and Immunology lectureship, the Jerry Elliot Memorial lectureship of the South Central Conference on Perinatal Research, the Japanese Society of Pediatric Pulmonology lectureship, the Benjamin Burrows Lung Immunology lectureship of the University of Arizona, the Frank P. Anderson Memorial lectureship of the Medical College of Georgia, the Robert H. Schwartz Lectureship in the Genetics of Pediatric Disease of the University of Rochester, and endowed lectureships from the Medical University of South Carolina, University of Louisville, and University of South Florida.  

Awards: Dr. Piedimonte is the recipient of a 1997 Career Investigator Award of the American Lung Association, the 1999 Investigator Award of the Asthma and Allergy Foundation of America, and the 2008 Pfizer Visiting Professorship in Pulmonology. He is a fellow of both the American Academy of Pediatrics and the American College of Chest Physicians.

Professional Highlights

  • Chief, Division of Pediatric Pulmonology at University of Miami Miller School of Medicine
  • Professor  & Chairman of Pediatrics at West Virginia University School of Medicine
  • Physician-in-Chief of West Virginia University Children’s Hospital
  • Chairman of the Pediatric Institute at Cleveland Clinic
  • Physician-in-Chief of Cleveland Clinic Children’s
  • President of Cleveland Clinic Children’s Hospital for Rehabilitation
  • Professor of Pediatrics at Case Western Reserve University

Education & Fellowships

Fellowship - University of North Carolina Hospitals
Pediatric Pulmonology
Chapel Hill, NC USA
1995
Research Fellowship - University of California San Francisco Medical Center
Pediatric
San Francisco, CA USA
1993
Internship - University of California San Francisco Medical Center
Pediatrics
San Francisco, CA USA
1992
Residency - University of Rome La Sapienza
Pediatrics
Rome Italy
1988
Medical School - University of Rome La Sapienza
Rome Italy
1986

Certifications

  • Pediatrics
  • Pediatrics- Pediatric Pulmonology

Treatment & Services

  • Center for Pediatric Pulmonology

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/20/2016, Dr. Piedimonte has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English